Matthew Hayes

Matthew Hayes is the Founder and Chief Technology Officer of Evonetix Ltd, a pioneering biotechnology company focused on innovative DNA synthesis technologies. Established in 2015, Evonetix aims to revolutionize the field of synthetic biology by enabling rapid, benchtop DNA synthesis directly in laboratories, thereby reducing reliance on external service providers.1

Educational Background

Matthew holds a PhD in Opto-Electronics and an MEng in Electrical and Electronic Engineering, both from Loughborough University. His academic background has significantly influenced his work in technology development within the biotechnology sector.1

Professional Experience

Before founding Evonetix, Matthew was the Head of Technology for the Global Medtech Division at Cambridge Consultants, where he led numerous complex projects. His extensive experience also includes roles as a Senior Engineer and Technical Director, showcasing his expertise in medical device development, ASIC design, and opto-electronics.13

Contributions to Evonetix

At Evonetix, Matthew has been instrumental in developing a unique platform that integrates chip technology, synthesis chemistry, and an error-removing assembly process. This innovative approach allows for high-throughput DNA synthesis, significantly accelerating the design-build-test cycle for researchers.13 Under his leadership, the company has expanded its team and secured substantial funding to advance its technology further.

Current Role

In addition to his role at Evonetix, Matthew has held various leadership positions in both corporate and academic settings, emphasizing his commitment to advancing technology in healthcare and synthetic biology.23

Overall, Matthew Hayes is recognized for his contributions to the biotechnology field and his vision for making DNA synthesis more accessible to researchers worldwide.